Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centre, randomised trial

Thrombosis and Haemostasis

Volumn 103, Issue 2, 2010, Pages 351-359

  Kenet, Gili ^a   Stenmo, Camilla B ^b   Blemings, Allan ^b,g   Wegert, Wolfgang ^c,h   Goudemand, Jenny ^d   Krause, Manuela ^c,e   Schramm, Wolfgang ^f   Kirchmaier, Carl ^c,h   Martinowitz, Uri ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b NOVO NORDISK A S   (Denmark)

^c DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g Ferring Pharmaceuticals A/S   (Germany)

^h WW YES Pharmaceutical Services GmbH   (Germany)

Author keywords

Haemophilia; Recombinant activated factor VII; ROTEM; TEG; Thromboelastography

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FATALITY; EX VIVO STUDY; FEMALE; FLUSHING; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; HYPERTENSION; IN VIVO STUDY; MALE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TACHYCARDIA; THERAPY EFFECT; THROMBOELASTOGRAPHY; TREATMENT DURATION;

EID: 75749152988     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-04-0212     Document Type: Article

References (21)

1. Salooja N, Perry DJ. Thromboelastography. Blood Coagul Fibrinolysis 2001; 12: 327-337.
2. Rivard GE, Brummel-Ziedins KE, Mann KG, et al. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005; 3: 2039-2043.
3. Luddington RJ. Thromboelastography/thromboelastometry. Clin Lab Haem 2005; 27: 81-90.
4. Koh MBC, Hunt BJ. The management of perioperative bleeding. Blood Rev 2003; 17: 179-185.
5. Sørensen B, Ingerslev J. Thromboelastography and recombinant factor VIIa - hemophilia and beyond. Semin Hematol 2004; 41 (1 Suppl 1): 140-144.
6. Carr JR ME, Martin EJ, Kuhn JG, et al. Monitoring of hemostatic status in four subjects being treated with recombinant factor VIIa. Clin Lab 2004; 50: 529-538.
7. Kawaguchi C, Takahashi Y, Hanesaka Y, et al. The in vitro analysis of the coagulation mechanism of activated factor VII using thrombelastogram. Thromb Haemost 2002; 88: 768-772.
8. Ingerslev J, Christiansen K, Calatzis A, et al. Management and monitoring of recombinant activated factor VII. Blood Coagul Fibrinolysis 2000; 11 (Suppl 1): S25-S30.
9. DiMichele D. Inhibitors: resolving diagnostic and therapeutic dilemmas. Haemophilia 2002; 8: 280-287.
10. Barr RD, Saleh M, Furlong W, et al. Health status and health-related quality of life associated with hemophilia. Am J Hematol 2002; 71: 152-160.
11. Gabriel DA, Carr M, Roberts HR. Monitoring coagulation and the clinical effects of recombinant factor VIIa. Semin Hematol 2004; 41 (Suppl 1): 20-24.
12. Key NS, Nelsestuen GL. Views on methods for monitoring recombinant factor VIIa in inhibitor patients. Semin Hematol 2004; 41 (1 Suppl 1): 51-54.
13. Sørensen B, Johansen P, Christiansen K, et al. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J Thromb Haemost 2003; 1: 551-558.
14. Young G, Blain R, Nakagawa P, et al. Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography. Haemophilia 2006; 12: 598-604.
15. Sørensen B, Ingerslev J. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thromboelastography. Haemophilia 2005; 11 (Suppl 1): 1-6.
16. Sørensen B, Ingerslev J. Whole blood clot formation phenotypes on haemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004; 2: 102-110.
17. ROTEM®. Available at: http://www.rotem.de. Accessed March 24, 2009.
18. TEG®. Available at: http://www.haemoscope.com. Accessed March 24, 2009.
19. Chitlur M, Warrier I, Rajpurkar M, et al. Thromboelastography in children with coagulation factor deficiencies. Br J Haematol 2008; 142: 250-256.
20. Nielsen VG. A comparison of the Thrombelastograph and the ROTEM. Blood Coagul Fibrinolysis 2007: 18: 247-252.
21. Young G, Ebbesen LS, Viuff D, et al. Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial. Blood Coagul Fibrinolysis 2008; 19: 276-282.